OVERVIEW

Hemophilia: Prophylaxis, Adherence, and Transitioning: Challenges in Young Adults is organized by EXCEL Continuing Education.

Released: June 3, 2020
Expires: June 3, 2021

Intended Audience:
Hematologists, internal medicine, family practice, emergency physicians, and other HCPs involved in the care of patients with hemophilia.

Accreditation:
Designation Statement:
EXCEL Continuing Education designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credits™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Part II Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.

Program Description
Section 1 of a 3-part series. Hemophilia, primarily diagnosed in infancy and early childhood, is a genetic disorder characterized by spontaneous or excessive bleeding predominantly into the weight-bearing joints or muscles. Most individuals are impacted through adolescence, adulthood, and into old age. This CME-accredited activity will review recent breakthroughs addressing the limitations of regular, prophylactic infusion of missing coagulation factors VIII/IX, discuss current and emerging therapies and treatment regimens, highlight risks and prevention of progressive degenerative joint changes, and explore practical implications of novel developments, while addressing “transition strategies” for adolescent care in the changing landscape of hemophilia.

Educational Objectives:
At the conclusion of this activity, participants should be able to:
• Identify the management barriers and needs of young adults with hemophilia when transitioning to adult hemophilia treatment centers (HTCs)
• Describe the current use and underuse of prophylactic factor VIII replacement therapy